- Home
- Publications
- Publication Search
- Publication Details
Title
RGD-mediated delivery of small-molecule drugs
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 9, Issue 6, Pages 579-604
Publisher
Future Science, LTD
Online
2017-04-11
DOI
10.4155/fmc-2017-0008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery
- (2016) Y. Gilad et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells
- (2016) Y. Gilad et al. BIOPOLYMERS
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Synthesis of Novel Protected Nα(ω-Drug) Amino Acid Building Units for Facile Preparation of Anticancer Drug-Conjugates
- (2016) Y. Gilad et al. International Journal of Peptide Research and Therapeutics
- RGD peptide conjugation results in enhanced antitumor activity of PD0325901 against glioblastoma by both tumor-targeting delivery and combination therapy
- (2016) Jianjun Hou et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeted Drug Delivery System for Platinum-based Anticancer Drugs
- (2016) Chuanzhu Gao et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide
- (2016) Jinfang Jiang et al. Drug Design Development and Therapy
- A platinum prodrug conjugated with a photosensitizer with aggregation-induced emission (AIE) characteristics for drug activation monitoring and combinatorial photodynamic–chemotherapy against cisplatin resistant cancer cells
- (2015) Youyong Yuan et al. CHEMICAL COMMUNICATIONS
- An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: synthesis and photoactivation studies
- (2015) Albert Gandioso et al. CHEMICAL COMMUNICATIONS
- Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers
- (2015) Alberto Dal Corso et al. CHEMISTRY-A EUROPEAN JOURNAL
- ?v?3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology
- (2015) Alberto Dal Corso et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Integrin-targeted delivery into cancer cells of a Pt(iv) pro-drug through conjugation to RGD-containing peptides
- (2015) Anna Massaguer et al. DALTON TRANSACTIONS
- Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD–paclitaxel conjugates for integrin-assisted drug delivery
- (2015) A. Bianchi et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- RGD-peptides modifying dexamethasone: to enhance the anti-inflammatory efficacy and limit the risk of osteoporosis
- (2015) Hualong Yu et al. MedChemComm
- Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3Integrin and VEGF Receptors
- (2015) Simone Zanella et al. ChemistryOpen
- Tumor-Selective Response to Antibody-Mediated Targeting of αvβ3 Integrin in Ovarian Cancer
- (2015) Charles N. Landen et al. NEOPLASIA
- Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking
- (2014) Youyong Yuan et al. CHEMICAL COMMUNICATIONS
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Dual Targeting of Integrin v 3 and Matrix Metalloproteinase-2 for Optical Imaging of Tumors and Chemotherapeutic Delivery
- (2014) J. L. Crisp et al. MOLECULAR CANCER THERAPEUTICS
- Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting αvβ3/αvβ5 integrins and IAP proteins
- (2014) M. Mingozzi et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Small-molecule SMAC mimetics as new cancer therapeutics
- (2014) Longchuan Bai et al. PHARMACOLOGY & THERAPEUTICS
- Clinical Comparison between Paclitaxel Liposome (Lipusu®) and Paclitaxel for Treatment of Patients with Metastatic Gastric Cancer
- (2013) Xu Xu et al. Asian Pacific Journal of Cancer Prevention
- The Functions and Applications of RGD in Tumor Therapy and Tissue Engineering
- (2013) Fen Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Conjugates of Modified Cryptophycins and RGD-Peptides Enter Target Cells by Endocytosis
- (2013) Markus Nahrwold et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Evaluation of RGD-Conjugated MEK1/2 Kinase Inhibitors for Integrin-Targeted Cancer Therapy
- (2013) Xiaoxiao Li et al. MOLECULES
- Tumor Targeting via Integrin Ligands
- (2013) Udaya Kiran Marelli et al. Frontiers in Oncology
- Design, Synthesis, and Biological Evaluation of Novel cRGD–Paclitaxel Conjugates for Integrin-Assisted Drug Delivery
- (2012) Michael Pilkington-Miksa et al. BIOCONJUGATE CHEMISTRY
- Radiolabelled RGD peptides for imaging and therapy
- (2012) F. C. Gaertner et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography
- (2012) Mark D. Bartholomä INORGANICA CHIMICA ACTA
- Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine–Glycine–Aspartate (RGD) Peptidomimetic–Paclitaxel Conjugates Targeting Integrin αVβ3
- (2012) Raffaele Colombo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Direct Fluorescence Monitoring of the Delivery and Cellular Uptake of a Cancer-Targeted RGD Peptide-Appended Naphthalimide Theragnostic Prodrug
- (2012) Min Hee Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- Integrin Targeting for Tumor Optical Imaging
- (2012) Yunpeng Ye et al. Theranostics
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- Aggregation-induced emission
- (2011) Yuning Hong et al. CHEMICAL SOCIETY REVIEWS
- Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies
- (2011) David A Reardon et al. Future Oncology
- Characterization of a Designed Vascular Endothelial Growth Factor Receptor Antagonist Helical Peptide with Antiangiogenic Activity in Vivo
- (2011) Anna Basile et al. JOURNAL OF MEDICINAL CHEMISTRY
- Conjugates of a Novel 7-Substituted Camptothecin with RGD-Peptides as αvβ3Integrin Ligands: An Approach to Tumor-Targeted Therapy
- (2010) Alma Dal Pozzo et al. BIOCONJUGATE CHEMISTRY
- Glucocorticosteroids: current and future directions
- (2010) Peter J Barnes BRITISH JOURNAL OF PHARMACOLOGY
- A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
- (2010) E. B. Haura et al. CLINICAL CANCER RESEARCH
- Targeting αvβ3 Integrin: Design and Applications of Mono- and Multifunctional RGD-Based Peptides and Semipeptides
- (2010) L. Auzzas et al. CURRENT MEDICINAL CHEMISTRY
- Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: An in vitro and in vivo evaluation study
- (2010) Bakheet Elsadek et al. EUROPEAN JOURNAL OF CANCER
- Cancer Therapies Utilizing the Camptothecins: A Review of thein VivoLiterature
- (2010) Vincent J. Venditto et al. MOLECULAR PHARMACEUTICS
- The Synthesis of a c(RGDyK) Targeted SN38 Prodrug with an Indolequinone Structure for Bioreductive Drug Release
- (2010) Baohua Huang et al. ORGANIC LETTERS
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Cooperation between integrin ανβ3 and VEGFR2 in angiogenesis
- (2009) Payaningal R. Somanath et al. ANGIOGENESIS
- Novel tumor-targeted RGD peptide–camptothecin conjugates: Synthesis and biological evaluation
- (2009) Alma Dal Pozzo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Function and Antagonism of β Integrins in the Development of Cancer Therapy
- (2009) H. Sheldrake et al. CURRENT CANCER DRUG TARGETS
- Tumor suppressor KAI1 affects integrin αvβ3-mediated ovarian cancer cell adhesion, motility, and proliferation
- (2009) Zlatna Ruseva et al. EXPERIMENTAL CELL RESEARCH
- Tubulin-Interactive Natural Products as Anticancer Agents(1)
- (2009) David G. I. Kingston JOURNAL OF NATURAL PRODUCTS
- Small Molecule Integrin Antagonists in Cancer Therapy
- (2009) Mayra Paolillo et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- The functional role of cell adhesion molecules in tumor angiogenesis
- (2009) Chiara Francavilla et al. SEMINARS IN CANCER BIOLOGY
- In Vitroandin VivoEvaluation of Doxorubicin Conjugates with the Divalent Peptide E-[c(RGDfK)2] that Targets Integrin αvβ3
- (2008) Claudia Ryppa et al. BIOCONJUGATE CHEMISTRY
- Tumor necrosis is associated with increased alphavbeta3integrin expression and poor prognosis in nodular cutaneous melanomas
- (2008) Ingeborg M Bachmann et al. BMC CANCER
- Expression of Integrin αvβ3in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature
- (2008) Oliver Schnell et al. BRAIN PATHOLOGY
- Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
- (2008) H. Choy et al. CLINICAL CANCER RESEARCH
- Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide–paclitaxel conjugate in mice with breast cancer
- (2008) Qizhen Cao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Integrin αvβ3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells
- (2008) Daniela Lössner et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
- (2007) Sumitra Mukhopadhyay et al. BIOCONJUGATE CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started